No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited delivers contract research and manufacturing solutions to the global and Indian pharmaceutical sectors. The company's activities are structured across two principal segments: Contract Research and Manufacturing Services, and Marketable Molecules. Its comprehensive product range encompasses the production and distribution of bulk drugs, active pharmaceutical ingredients (APIs), including both generic and highly potent varieties. Furthermore, it supplies specialized chemical compounds such as phase transfer catalysts, quaternary ammonium compounds, phosphoranes, and Wittig reagents, alongside a variety of vitamin D products and their analogues, cholesterol, lanolin-derived products, and other fine chemicals. Dishman Carbogen Amcis also offers consumer-oriented items like hand and body wash, sanitizers, antiseptics, and various disinfectant formulations, in addition to diverse pharmaceutical and cosmetic goods. Dishman Carbogen Amcis Limited functions as a subsidiary of Adimans Technologies LLP.
imdcal.comNo one on the platform currently holds DCAL.BO.
No tracked institution reports a position in DCAL.BO as of their last filing.
No one on the platform has traded DCAL.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-20 | $4.00 | $1.39 | -65.3% |
| 2026-02-10 | $4.00 | $-0.83 | -120.8% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DCAL.BODishman Carbogen Amcis Limited | $162.85 | -2.78% | $25.6B | — |
| AARTIDRUGS.BOAarti Drugs Limited | $426.85 | -0.32% | $39.0B | — |
| AARTIDRUGS.NSAarti Drugs Limited | $426.35 | -0.50% | $38.9B | — |
| INNOVACAP.NSInnova Captab Limited | $1140.10 | -0.62% | $65.2B | — |
| SPARC.BOSun Pharma Advanced Research Company Limited | $188.20 | -4.03% | $60.9B | — |
| SPARC.NSSun Pharma Advanced Research Company Limited | $188.00 | -4.09% | $61.0B | — |
| SUPRIYA.BOSupriya Lifescience Ltd | $874.70 | -2.81% | $70.4B | — |
Source: Financial Modeling Prep · peers by sector/industry